• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国老年人群中白血病而非所有癌症发病率迅速上升的新趋势。

An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States.

机构信息

Department of Cancer Biology, Beckman Research Institute, City of Hope, Duarte, CA, 91010, USA.

Department of Biostatistics, Beckman Research Institute, City of Hope, Duarte, CA, 91010, USA.

出版信息

Sci Rep. 2019 Aug 19;9(1):12070. doi: 10.1038/s41598-019-48445-1.

DOI:10.1038/s41598-019-48445-1
PMID:31427635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6700310/
Abstract

The "baby boomers" born in 1946-1964 in the United States (U.S.) started to reach the age of 65 in 2011, rapidly accelerating U.S. population aging. There are great public concerns about its impact on health care with anticipation of rising cancer incidences. We examined the incidences and deaths of leukemia and overall cancer in the U.S. from 1998 to 2018. The acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) incidences remained constant prior to 2011 but have climbed up substantially since then, and the chronic lymphocytic leukemia (CLL) incidence has increased continuously since 1998. The significant increase of myeloid leukemia and CLL incidences was strongly correlated with the U.S. population aging. The incidence of all cancers was increased in correlation with a small increase in aging population prior to 2011, but surprisingly has changed marginally since 2011, which was not significantly correlated with the accelerated population aging. We observed the most substantial decline of deaths with CML, whereas AML deaths continued to rise in the past 20 years. In conclusion, the overall cancer incidence was not increased as fast as previously feared with aging Americans; however, the incidences of myeloid leukemia and CLL significantly outpaced that of all cancers.

摘要

1946-1964 年出生于美国的“婴儿潮一代”于 2011 年开始达到 65 岁,这迅速加速了美国人口老龄化。人们普遍担心这会对医疗保健产生影响,预计癌症发病率会上升。我们研究了 1998 年至 2018 年美国白血病和所有癌症的发病率和死亡率。急性髓细胞白血病(AML)和慢性髓细胞白血病(CML)的发病率在 2011 年之前保持不变,但此后大幅上升,慢性淋巴细胞白血病(CLL)的发病率自 1998 年以来持续上升。髓性白血病和 CLL 发病率的显著增加与美国人口老龄化密切相关。所有癌症的发病率与 2011 年前人口老龄化的少量增加相关联,但自 2011 年以来变化不大,与人口老龄化的加速没有显著相关性。我们观察到 CML 的死亡率下降幅度最大,而 AML 的死亡率在过去 20 年中持续上升。总之,随着美国老年人的老龄化,总体癌症发病率并没有像之前担心的那样迅速上升;然而,髓性白血病和 CLL 的发病率明显超过了所有癌症。

相似文献

1
An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States.美国老年人群中白血病而非所有癌症发病率迅速上升的新趋势。
Sci Rep. 2019 Aug 19;9(1):12070. doi: 10.1038/s41598-019-48445-1.
2
Three hematologic malignancies in the same patient: chronic lymphocytic leukemia, followed by chronic myeloid leukemia and acute myeloid leukemia.同一患者患三种血液系统恶性肿瘤:慢性淋巴细胞白血病,继之慢性髓系白血病和急性髓系白血病。
Clin Lab. 2014;60(11):1929-32. doi: 10.7754/clin.lab.2014.140315.
3
Trends in leukemia incidence and survival in the United States (1973-1998).美国白血病发病率及生存率趋势(1973 - 1998年)
Cancer. 2003 May 1;97(9):2229-35. doi: 10.1002/cncr.11316.
4
Chronic Myelogenous Leukemia Diagnosed in the Setting of Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.在未经治疗的慢性淋巴细胞白血病/小淋巴细胞淋巴瘤背景下诊断出的慢性粒细胞白血病
Int J Surg Pathol. 2020 Apr;28(2):216-224. doi: 10.1177/1066896919876704. Epub 2019 Sep 22.
5
Specific cutaneous infiltrates in patients with myelogenous leukemia: a clinicopathologic study of 26 patients with assessment of diagnostic criteria.骨髓性白血病患者的特异性皮肤浸润:一项对26例患者的临床病理研究及诊断标准评估
J Am Acad Dermatol. 1999 Jun;40(6 Pt 1):966-78. doi: 10.1016/s0190-9622(99)70086-1.
6
Survival for patients with chronic leukemias in the US and Britain: Age-related disparities and changes in the early 21st century.美国和英国慢性白血病患者的生存率:年龄相关差异及21世纪初的变化
Eur J Haematol. 2015 Jun;94(6):540-5. doi: 10.1111/ejh.12468. Epub 2015 Feb 4.
7
Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.异基因造血干细胞移植后巨细胞病毒再激活与移植后存活至第100天的急性髓系白血病患者复发风险降低相关:日本造血细胞移植学会移植相关并发症工作组
Biol Blood Marrow Transplant. 2015 Nov;21(11):2008-16. doi: 10.1016/j.bbmt.2015.07.019. Epub 2015 Jul 26.
8
[Descriptive epidemiology of myeloid leukemia].[髓系白血病的描述性流行病学]
Nihon Rinsho. 2009 Oct;67(10):1847-51.
9
Patterns of occurrence of the leukaemias.白血病的发病模式。
Eur J Cancer. 1995 Jun;31A(6):941-9. doi: 10.1016/0959-8049(95)00024-0.
10
Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.急性和慢性白血病在体外培养前后的端粒酶活性和端粒长度
Cancer Res. 2000 Feb 1;60(3):610-7.

引用本文的文献

1
Regional, demographic, and temporal trends in myeloid leukemia mortality in the United States (1999-2022): a comprehensive analysis using CDC WONDER.美国髓系白血病死亡率的地区、人口统计学和时间趋势(1999 - 2022年):使用疾病控制与预防中心(CDC)WONDER进行的综合分析
Front Oncol. 2025 Jul 11;15:1560797. doi: 10.3389/fonc.2025.1560797. eCollection 2025.
2
Immunopathological Dysregulation in Acute Myeloid Leukemia: The Impact of T-bet, RORγt, and FOXP3 on Disease Dynamics.急性髓系白血病中的免疫病理失调:T-bet、RORγt和FOXP3对疾病动态的影响
Cells. 2025 Apr 1;14(7):528. doi: 10.3390/cells14070528.
3
Synthesis and Biological Evaluation of Quercetagetin Derivatives as the Inhibitors of Mcl-1 and Bcl-2 Against Leukemia.

本文引用的文献

1
Analysis of acute myeloid leukemia incidence and geographic distribution in Canada from 1992 to 2010 reveals disease clusters in Sarnia and other industrial US border cities in Ontario.分析 1992 年至 2010 年加拿大急性髓细胞白血病的发病率和地理分布,揭示了安大略省萨尼亚和其他美国边境工业城市的疾病聚集。
Cancer. 2019 Jun 1;125(11):1886-1897. doi: 10.1002/cncr.32034. Epub 2019 Feb 27.
2
Declining cancer incidence at the oldest ages: Hallmark of aging or lower diagnostic activity?最年长人群癌症发病率下降:衰老的标志还是诊断活动减少?
J Geriatr Oncol. 2019 Sep;10(5):792-798. doi: 10.1016/j.jgo.2019.02.001. Epub 2019 Feb 21.
3
作为Mcl-1和Bcl-2抑制剂的槲皮万寿菊素衍生物的合成及其对白血病的生物学评价
Int J Mol Sci. 2025 Mar 18;26(6):2727. doi: 10.3390/ijms26062727.
4
Emerging nanocarriers as advanced delivery tools for the treatment of leukemia.新兴纳米载体作为治疗白血病的先进递送工具。
Nanomedicine (Lond). 2025 Apr;20(7):725-735. doi: 10.1080/17435889.2025.2466409. Epub 2025 Feb 21.
5
Cost-effectiveness of acalabrutinib monotherapy or with obinutuzumab versus chemoimmunotherapy for untreated chronic lymphocytic leukemia in China.在中国,阿卡拉布替尼单药治疗或联合奥滨尤妥珠单抗与化学免疫疗法用于初治慢性淋巴细胞白血病的成本效益分析。
Ther Adv Hematol. 2024 Nov 8;15:20406207241295559. doi: 10.1177/20406207241295559. eCollection 2024.
6
Splicing the Difference: Harnessing the Complexity of the Transcriptome in Hematopoiesis.拼接差异:利用造血过程中转录组的复杂性
Exp Hematol. 2024 Dec;140:104655. doi: 10.1016/j.exphem.2024.104655. Epub 2024 Oct 10.
7
Healthcare resource utilization and costs of chronic lymphocytic leukemia/small lymphocytic lymphoma patients who relapse or are refractory to ibrutinib.伊布替尼治疗后复发或耐药的慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者的医疗资源利用和成本。
Future Oncol. 2024;20(35):2723-2735. doi: 10.1080/14796694.2024.2390351. Epub 2024 Oct 7.
8
Comparison of Epstein-Barr virus copy number in white blood cells of chronic lymphocytic leukemia patients with laboratory prognostic biomarker.慢性淋巴细胞白血病患者白细胞中爱泼斯坦-巴尔病毒拷贝数与实验室预后生物标志物的比较。
BMC Res Notes. 2024 Oct 1;17(1):281. doi: 10.1186/s13104-024-06942-1.
9
Age-associated myeloid malignancies - the role of STAT3 and STAT5 in myelodysplastic syndrome and acute myeloid leukemia.年龄相关性髓系恶性肿瘤 - STAT3 和 STAT5 在骨髓增生异常综合征和急性髓系白血病中的作用。
FEBS Lett. 2024 Nov;598(22):2809-2828. doi: 10.1002/1873-3468.14985. Epub 2024 Jul 24.
10
Leukemia in India: Insights Into Incidence, Prevalence, Mortality, and Disability-Adjusted Life Years.印度的白血病:发病率、患病率、死亡率及伤残调整生命年洞察
Cureus. 2024 Jun 17;16(6):e62557. doi: 10.7759/cureus.62557. eCollection 2024 Jun.
Incidence, Survival, and Risk Factors for Adults with Acute Myeloid Leukemia Not Otherwise Specified and Acute Myeloid Leukemia with Recurrent Genetic Abnormalities: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database, 2001-2013.
2001 - 2013年监测、流行病学和最终结果(SEER)数据库分析:成人非特殊类型急性髓系白血病及伴有复发性基因异常的急性髓系白血病的发病率、生存率和危险因素
Acta Haematol. 2018;139(2):115-127. doi: 10.1159/000486228. Epub 2018 Feb 16.
4
Incidence of acute lymphocytic leukemia in Calgary, Alberta, Canada: a retrospective cohort study.加拿大艾伯塔省卡尔加里市急性淋巴细胞白血病的发病率:一项回顾性队列研究。
BMC Res Notes. 2018 Feb 7;11(1):104. doi: 10.1186/s13104-018-3225-9.
5
Challenges in assessing the real incidence of chronic lymphocytic leukemia: 16 years of epidemiological data from the province of Girona, Spain.评估慢性淋巴细胞白血病实际发病率面临的挑战:来自西班牙赫罗纳省的16年流行病学数据
Cancer Causes Control. 2018 Mar;29(3):379-382. doi: 10.1007/s10552-018-1004-5. Epub 2018 Jan 30.
6
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
7
Aging of hematopoietic stem cells.造血干细胞的衰老。
Blood. 2018 Feb 1;131(5):479-487. doi: 10.1182/blood-2017-06-746412. Epub 2017 Nov 15.
8
Therapy-related myeloid neoplasms: when genetics and environment collide.治疗相关的髓系肿瘤:遗传学与环境的碰撞
Nat Rev Cancer. 2017 Aug 24;17(9):513-527. doi: 10.1038/nrc.2017.60.
9
Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment.慢性淋巴细胞白血病:2017 年诊断、风险分层和治疗更新。
Am J Hematol. 2017 Sep;92(9):946-965. doi: 10.1002/ajh.24826.
10
Cancer-Incidence, prevalence and mortality in the oldest-old. A comprehensive review.高龄老人的癌症发病率、患病率和死亡率。一项综合综述。
Mech Ageing Dev. 2017 Jun;164:113-126. doi: 10.1016/j.mad.2017.05.002. Epub 2017 May 11.